[go: up one dir, main page]

Suzuki et al., 2002 - Google Patents

Physical property of troglitazone, an equal mixture of four stereoisomers

Suzuki et al., 2002

Document ID
8632102962314712808
Author
Suzuki N
Kasahara K
Hasegawa H
Kawasaki T
Publication year
Publication venue
International journal of pharmaceutics

External Links

Snippet

Troglitazone, an oral antidiabetic agent, is an equal mixture of four stereoisomers involving two chiral centers. In the present study, the physical property of troglitazone were investigated. The solid state of troglitazone drug substance is characterized as a simple …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems

Similar Documents

Publication Publication Date Title
US20210261556A1 (en) Short-acting benzodiazepine salts and their polymorphic forms
DK2318365T3 (en) NOVEL polymorphic forms of perindopril (L) -arginine AND PROCESS FOR PREPARATION THEREOF
CA2657369C (en) Short-acting benzodiazepine salts and their polymorphic forms
BR112012007092B1 (en) Method for preparing a crystalline form of a 1-chloro-4- (beta-d-glycopyran-1-yl) -2- [4 - ((s) -tetrahydro-furan-3-yloxy) benzyl) benzene compound
JP2007502272A (en) 6- (2,2,2-trifluoroethylamino) -7-chloro-2,3,4,5-tetrahydro-1H-benzo [d] azepine as a 5-HT2C receptor agonist
TW202220962A (en) Crystal form of selective nav inhibitor and preparation method thereof
CN102281877A (en) novel forms of bendamustine free base
US20110275679A1 (en) Flupirtine hydrochloride maleic acid cocrystal
Suzuki et al. Physical property of troglitazone, an equal mixture of four stereoisomers
Chen et al. Cocrystals of zileuton with enhanced physical stability
JP2021507927A (en) Crystal form of barbenazintosilate and its production method and application
KR20200071090A (en) Edarabon salt
KR20240125003A (en) Pharmaceutically acceptable salts, crystal forms and methods for preparing the same of GLP-1 receptor agonists
EP3724198B1 (en) 2-oxo-1-pyrrolidinyl imidazothiadiazole derivatives
Espadinha et al. Identification of tetracyclic lactams as NMDA receptor antagonists with potential application in neurological disorders
Kushida Quantitative crystallinity determination for E1010, a novel carbapenem antibiotic, using differential scanning calorimetry
BR112020026202A2 (en) benzoxazole derivative crystal
RU2787767C2 (en) Benzoxazole derivative crystal
TWI824626B (en) Crystal forms of RIPK1 inhibitors and their acid salts and crystal forms of their acid salts
EP3790885B1 (en) 1-imidazothiadiazolo-2h-pyrrol-5-one derivatives
Chen et al. Lenalidomide acesulfamate: Crystal structure, solid state characterization and dissolution performance
Suzuki et al. Solid-state variation of troglitazone drug substance by using a different recrystallization method
TW202333694A (en) Crystal form of fused ring derivative and preparation method and application thereof
KR20220088743A (en) Crystalline form of hypoxia-inducing factor-prolyl hydroxylase inhibitor
Ferdani et al. Solid state structures of N-2-(3-indolylethyl) aza-9-crown-3, N, N′-bis (2-(3-indolylethyl))-4, 13-diaza-18-crown-6, and their protonated forms